Information
GEXVal Featured in BioCentury Article
2025/12/22
GEXVal Inc.December 22, 2025 GEXVal Featured in BioCentury Article “Raising the Sun: Japan Biotech Looks to Le […]
GEXVal Senior Director Speaks at University of Tokyo Hospital Drug Discovery Training Program
2025/12/12
GEXVal Inc.December 12, 2025 GEXVal Senior Director Delivers Lecture at University of Tokyo Hospital TR/Academ […]
GEXVal CEO Speaks at University of Tokyo Hospital Drug Discovery Training Program
2025/11/21
GEXVal Inc.November 21, 2025 GEXVal CEO Delivers a Lecture at University of Tokyo Hospital TR/Academia Drug Di […]
GEXVal Receives FDA Orphan Drug Designation for GXV-001 in Fragile X Syndrome
2025/11/19
GEXVal Inc.November 19, 2025 GEXVal Receives FDA Orphan Drug Designation for GXV-001 in Fragile X Syndrome GEX […]